Microbiotica completes recruitment for phase 1b ulcerative colitis trial
Written by
PharmaTimes
Published
0
comments
0
min
MB310 study investigates safety and efficacy of precision microbiome therapy MB310 study investigates safety and efficacy of precision microbiome therapy